Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 6/20 | 0.46 |
| ▸ | CTSB | P07858 | 3/20 | 0.44 |
| ▸ | CALCRL | Q16602 | 4/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | REN | P00797 | 3/20 | 0.43 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | FCGRT | P55899 | 2/20 | 0.40 |
| ▸ | CALCR | P30988 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31483268 | 0.89 | REN (0.48) | CAPN1CTSBREN | |
| SCHEMBL29591887 | 0.86 | REN (0.47) | CAPN1CTSBSLC6A2REN | |
| SCHEMBL30253903 | 0.84 | SLC6A2 (0.51) | CALCRLSLC6A2REN | |
| SCHEMBL31488462 | 0.84 | CALCRL (0.47) | CAPN1CTSBCALCRLSLC6A2REN | |
| SCHEMBL30498899 | 0.83 | SLC6A2 (0.42) | CAPN1CTSBCALCRLSLC6A2REN | |
| SCHEMBL29384601 | 0.83 | SLC6A2 (0.52) | CAPN1CALCRLSLC6A2RENCALCR | |
| SCHEMBL29845324 | 0.82 | REN (0.46) | SLC6A2REN | |
| SCHEMBL29630596 | 0.82 | MEN1 (0.43) | CAPN1CTSBREN | |
| SCHEMBL29608127 | 0.82 | REN (0.49) | CAPN1SLC6A2RENCALCR | |
| SCHEMBL31318919 | 0.82 | CALCRL (0.46) | CALCRLRENCALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119841894-A | ACE and alpha-glucosidase inhibitory peptide derived from flammulina velutipes and application thereof | 青岛农业大学 | 2025-04-18 | — | — | CN | disclosed |